NVCT vs PARA · $304.5M cap vs rev $5.0M
Nuvectis Pharma Inc (NVCT) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
NVCT does not have a complete income-statement cache yet.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
NVCT currently screens at market cap $304.5M. PARA currently screens at market cap $0.
Not investment advice. Open the NVCT and PARA stock pages for the full models.
Not investment advice.